Publications by authors named "Mark Dowar"

Claim this Profile
C
CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling.
David T Mulder, Etienne R Mahé, Mark Dowar, Youstina Hanna, Tiantian Li

Blood Adv· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
S Y Cindy Yang, Stephanie Lheureux, Katherine Karakasis, Julia V Burnier, Jeffery P Bruce, Mark Dowar

Genome Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Olena Kis, Rayan Kaedbey, Signy Chow, Arnavaz Danesh, Mark Dowar

Nat Commun· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition.
Stephanie Lheureux, Jeff P Bruce, Julia V Burnier, Katherine Karakasis, Patricia A Shaw, Mark Dowar

J Clin Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic landscape of schwannoma.
Sameer Agnihotri, Shahrzad Jalali, Mark R Wilson, Arnavaz Danesh, Mira Li, Mark Dowar

Nat Genet· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.
Swneke D Bailey, Kinjal Desai, Ken J Kron, Parisa Mazrooei, Nicholas A Sinnott-Armstrong, Mark Dowar

Nat Genet· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Hilmi Ozcelik, Xuejiang Shi, Martin C Chang, Eric Tram, Matt Vlasschaert, Mark Dowar

J Mol Diagn· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
Alon Vaisman, Steven Orlov, Jonathan Yip, Cindy Hu, Terence Lim, Mark Dowar

Head Neck· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma.
Steven Orlov, David Orlov, Michael Shaytzag, Mark Dowar, Vafa Tabatabaie

Head Neck· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Anna M Sawka, Steven Orlov, Jacob Gelberg, Barry Stork, Mark Dowar

Head Neck· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis